[ Pobierz całość w formacie PDF ]
.16.Interview, Steve Rauschenberger, January 16, 2001.CHAPTER EIGHT1.New Hampshire Senate Insurance Committee Hearing, SB 370 Relative toHealth Insurance Coverage for Scalp Hair Prostheses, January 1, 1992, pp.4 6.2.Jacob Hacker, The Divided Welfare State: The Battle over Public and Private SocialBenefits in the United States (Cambridge University Press, 2002), pp.11, 29.See alsoChristopher Howard, The Welfare State Nobody Knows: Debunking Myths about U.S.Social Policy (Princeton University Press, 2007), p.2.3.Interview, Wendy Royalty, January 15, 2002.4.Bob Rosenblatt, Viagra Spurs New Questions about HMO Drug Coverage, LosAngeles Times, June 8, 1998, p.8.5.Interview, Tracy Barnes, January 16, 2002.6.New Hampshire Senate Insurance Committee Hearing, p.14.7.Norman Daniels, Just Health Care (Cambridge University Press, 1985), p.33.8.M.L.Lyke, Viagra s Bitter Pill, Seattle Post-Intelligencer, May 14, 1998, p.A1.9.Robert Scheer, Dole Is Here to Remind Us: Sex Isn t Dirty; It s Been a YearViagra Notwithstanding in Which Sexual Excitement Has Hardly Been Treated as aGood Thing, Los Angeles Times, January 5, 1999, p.7.10.Interview, Paige Shipman, November 29, 2001.11.Interview, Jay Mahler, October 1, 2001.12.Interview, Tom Bruckman, January 29, 2002.13.Martha Fuller Clark, SB 175 Testimony, Senate Insurance Committee, NewHampshire, Document 2, March 29, 1999, p.3; Candace White Bouchard, SB 175 Tes- 0333-4-14 notes:Layout 1 10/29/09 3:45 PM Page 220220 NOTES TO PAGES 117 28timony, Senate Insurance Committee, New Hampshire, Document 3, March 29, 1999,p.1.14.Blue Cross/Blue Shield of New Hampshire/Matthew Thornton Health Plan, SB175 Testimony, Senate Insurance Committee, New Hampshire, Document 6, March 29,1999, p.1.15.Rickie Solinger, Beggars and Choosers: How the Politics of Choice Shapes Adoption,Abortion, and Welfare in the United States (New York: Hill and Wang, 2001).16.Interview, Ed Rivet, January 25, 2002; see also U.S.Newswire, Right to Life ofMichigan Commends President Bush as He Proclaims November as National AdoptionMonth, November 12, 2001.17.Interview, Jennifer Gosselin, October 12, 2001.18.See, for example, State of Illinois, 87th General Assembly, Regular Session, Sen-ate Transcript, 46th Legislative Day, June 19, 1991, p.48 (remarks of Sen.Raica).19.Interview, Susan Scherr, December 7, 2001.20.See, for example, Connie Ruggles, Findings of Fact and Recommendation, Case No.01-279, Subscriber vs.CIGNA HealthCare of Florida, State of FloridaStatewide Provider and Subscriber Assistance Panel, July 31, 2001; Frank E.Iaquinta,M.D., External Review Determination, IPRO, Lake Success, N.Y., July 26, 2001; JohnT.Price, M.D., Rationale for Full Review Decision, Connecticut External Review Pro-gram, re.decision denying coverage of June 25, 1999. 21.Frank E.Iaquinta, M.D., External Review Determination, IPRO, Lake Success,N.Y., May 8, 2001.22.Frank E.Iaquinta, M.D., External Review Determination, IPRO, Lake Success,N.Y., July 10, 2001.23.Frank E.Iaquinta, M.D., IPRO, Lake Success, N.Y., External Review ResponseFull Review, Letter to Susan F.Cogswell, Insurance Commissioner, State ofConnecticut, date redacted.24.Interview, Jack Bruner, January 23, 2002.25.Interview, Elvin Zook, January 23, 2002.CHAPTER NINE1.The first health care chapter, chapter 7, examined debate over the line betweenwhat public insurance should cover and what should be left instead to the responsibil-ity of private individuals and their families.The second health care chapter, chapter 8,looked at debates over how government should draw the line between private insuranceand the private individual s own responsibilities.This chapter completes the loop byexamining discourse over the border between public insurance and private insurance,and whether that border can remain stable over time.2.Pierre Rosanvallon, The New Social Question: Rethinking the Welfare State (Prince-ton University Press, 2000), p.16.3.Michael Graetz and Jerry Mashaw, True Security: Rethinking American SocialInsurance (Yale University Press, 1999), p.24. 0333-4-14 notes:Layout 1 10/29/09 3:45 PM Page 221NOTES TO PAGES 129 36 2214.Robert Reich, The Resurgent Liberal: And Other Unfashionable Prophecies (NewYork: Times Books, 1989), p.279.5.David Miller, Altruism and the Welfare State, in Responsibility, Rights, and Wel-fare: The Theory of the Welfare State, edited by J.Donald Moon (Boulder, Colo.: WestviewPress, 1988), p.165.See also Karl Ove Meone and Michael Wallerstein, Self-InterestedSupport for Welfare Spending, paper presented at the 1996 annual meeting of theAmerican Political Science Association, San Francisco, Aug.29 Sept.1, 1996, p.21.6.See also the discussion in Jacob S.Hacker, The Divided Welfare State: The Battleover Public and Private Social Benefits in the United States (Cambridge University Press,2002), p.29; and Beth Stevens, Blurring the Boundaries: How the Federal GovernmentHas Influenced Welfare Benefits in the Private Sector, in The Politics of Social Policy inthe United States, edited by Margaret Weir, Ann Shola Orloff, and Theda Skocpol(Princeton University Press, 1988), p.147.7.Tsung-mei Cheng and Uwe E.Reinhardt, The Ethics of America s Health CareDebate, in Uniting America: Restoring the Vital Center to American Democracy, editedby Norton Garfinkle and Daniel Yankelovich (Yale University Press, 2005), p.81.8.Robin Toner, Boiling Brew: Politics and Health Insurance Gap, New York Times,September 30, 2003, p.A27.9.Interview, Philip Boyle, November 28, 2001.10.Interview, Robert Pokorski, November 19, 2001.11.Amy Harmon, Burden of Knowledge: Tracking Prenatal Health in New Tests forFetal Defects, Agonizing Choices for Parents, New York Times, June 20, 2004, p.A4.Seealso Andrew Pollack, The Wide, Wild World of Genetic Testing, New York Times, Sep-tember 12, 2006, p.G4.12.Ted Halstead and Michael Lind, The Radical Center: The Future of AmericanPolitics (New York: Doubleday, 2001), p.78.13.Alexander Capron, Which Ills to Bear, Revaluating the Power of Modern Genet-ics, in Bioethics: Basic Writings on the Key Ethical Questions That Surround the MajorModern Biological Possibilities and Problems, edited by Thomas Anthony Shannon(Mahwah, N.J.: Paulist Press, 1993), p.497.14.Interview, Dorothy Wertz, November 26, 2001.15.Boyle interview.16.Philip J.Boyle, Shaping Priorities in Genetic Medicine, Hastings Center Report25, no.3 (1995), pp.S2 S8.17.Klaus Lindpaintner, The Impact of Pharmacogenetics and Pharmacoge-nomics, Journal of Commercial Biotechnology 10 (2003), p.71.18.Aravinda Chakravarti and Peter Little, Nature, Nurture and Human Disease, Nature 421, January 23, 2003, p.414; Editorial, Pharmacogenetics to Come, Nature425, October 23, 2003, p.749.19.Jai Shah, Economic and Regulatory Considerations in Pharmacogenomics forDrug Licensing and Healthcare, Nature Biotechnology 21 (2003), p.752.20.Interview, Julie Taylor, October 30, 2001.21.Interview, Ernest Csiszar, October 29, 2001. 0333-4-14 notes:Layout 1 10/29/09 3:45 PM Page 222222 NOTES TO PAGES 136 4622.See, for example, Charles Lockhart, Gaining Ground: Tailoring Social Programs toAmerican Values (University of California Press, 1989), p.22; Jacob S
[ Pobierz całość w formacie PDF ]